Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
8 studies found for:    "Alopecia totalis"
Show Display Options
Rank Status Study
1 Completed The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis
Conditions: Recalcitrant Alopecia Totalis;   Recalcitrant Alopecia Universalis
Interventions: Drug: Botulinum toxin A;   Drug: Normal saline injection
2 Withdrawn Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis
Condition: Alopecia Totalis/Universalis
Interventions: Drug: Abatacept;   Drug: Inactive infusion
3 Withdrawn Efalizumab in the Treatment of Alopecia, Phase II
Condition: Alopecia Totalis
Intervention: Drug: efalizumab
4 Completed Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
Conditions: Alopecia Totalis;   Alopecia Universalis;   Ophiasic Alopecia
Intervention: Drug: methylprednisolone sodium succinate
5 Recruiting Alopecia Areata Registry
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis;   Autoimmune Hair Loss;   Alopecia Partialis
6 Recruiting Tofacitnib for the Treatment of Alopecia Areata and Variants
Conditions: Alopecia Areata (AA);   Alopecia Totalis (AT);   Alopecia Universalis (AU)
Intervention: Drug: Tofacitinib Administration
7 Completed Plaquenil for Alopecia Areata, Alopecia Totalis
Condition: Alopecia Areata
Intervention: Drug: Hydroxychloroquine
8 Completed Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Targretin Gel 1%

Indicates status has not been verified in more than two years